Showing results (281-290 of 661) with videos related to
Sort By:
Pageof 67
Nature Cancer|January 16, 2026
Glucagon-like peptide-1 medicines and cancerJulian M Yabut, Daniel J DruckerNature Cancer|May 16, 2025
MCSP+ metastasis founder cells activate immunosuppression early in human melanoma metastatic colonizationSeverin Guetter, Courtney König, Huiqin Koerkel-Qu, et al.Nature Cancer|May 13, 2025
CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumorsFeiyu Chen, Haoyan Li, Yin Wang, et al.Nature Cancer|May 14, 2025
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of esophageal adenocarcinomaMelissa Barroux, Jacob Househam, Eszter Lakatos, et al.Nature Cancer|May 29, 2025
Cardiomyocyte-localized CCDC25 senses NET DNA to promote doxorubicin cardiotoxicity by activating autophagic fluxMan Nie, Dexin Lei, Zhou Liu, et al.Nature Cancer|May 9, 2025
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapyChao Wang, Xiaoqing Yu, Jamie K Teer, et al.Nature Cancer|July 18, 2025
Clonal hematopoiesis in myeloid malignancies and solid tumorsXiurong Cai, Robert L Bowman, Jennifer J TrowbridgeNature Cancer|July 22, 2025
Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancerJustin Huang, Willemijn S M E Theelen, Zineb Belcaid, et al.Nature Cancer|May 29, 2025
Glioblastoma shift from bulk to infiltrative growth is guided by plexin-B2-mediated microglia alignment in invasive nichesSangjo Kang, Mary E Ughetta, Jack Y Zhang, et al.Nature Cancer|June 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacyDong Hu, Xiaoshuang Lyu, Zheqi Li, et al.Pageof 67